Subscribe
viewimage / Shutterstock.com
13 June 2024NewsBiotechnologyMarisa Woutersen

Guardant Health files suit against Tempus AI

Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Guardant holds on to diagnostics patent following TwinStrand challenge
1 February 2024   PTAB says claims of genetic disease testing patent are not obvious | Rival biotech firm denied petition for invalidation.
Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Big Pharma
Guardant holds on to diagnostics patent following TwinStrand challenge
1 February 2024   PTAB says claims of genetic disease testing patent are not obvious | Rival biotech firm denied petition for invalidation.
Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.

More on this story

Big Pharma
Guardant holds on to diagnostics patent following TwinStrand challenge
1 February 2024   PTAB says claims of genetic disease testing patent are not obvious | Rival biotech firm denied petition for invalidation.
Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.

More features

Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
HLK adds CRISPR specialist as partner
UPC delivers first 'imminent infringement' decision in biosimilar dispute